Government policy to focus on drug reclassification and DUR activation.

Published: 2004-08-10 06:59:00

Updated: 2004-08-10 06:59:00

The government and the ruling Uri party discussed the sales ban on the PPA contained remedies and the future administrative and drug safety measures focusing on the drug reclassification and the enforcement of the DUR (Drug Use Review) system, a drug safety system administration and a thorough cl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK